Home › Interstitial Lung Diseases › Arizona › Tucson
Interstitial Lung Diseases clinical trials in Tucson, AZ
3 studies for Interstitial Lung Diseases are looking for participants at sites in and around Tucson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RecruitingObservational study
- University of Arizona, Tucson
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingPhase 2
- University of Arizona, Tucson
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RecruitingPhase 2/3
- GSK Investigational Site, Tucson
About Interstitial Lung Diseases
Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.
More about Interstitial Lung Diseases on MedlinePlus
Interstitial Lung Diseases trials in other cities
- New York City, NY17 studies
- Philadelphia, PA16 studies
- Los Angeles, CA14 studies
- Kansas City, KS13 studies
- Durham, NC13 studies
- Houston, TX12 studies
- Chicago, IL12 studies
- Charleston, SC11 studies
- Ann Arbor, MI11 studies
- Aurora, CO10 studies
- Boston, MA9 studies
- Rochester, MN9 studies
Other studies in Tucson
- Obesity20 studies
- Breast Cancer18 studies
- Non-Small Cell Lung Cancer18 studies
- Overweight17 studies
- Metastatic Cancer14 studies
- Type 2 Diabetes13 studies
- Cancer (all types)12 studies
- Prostate Cancer12 studies
- Colorectal Cancer11 studies
- Cardiovascular Disease11 studies
- Steatotic Liver Disease10 studies
- Acute Myeloid Leukemia10 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.